Auto-populated list of related Clinical Trials
(Breast, Cleft Lip and Palate, Hand, Lymphedema, Oral, Skin, Trauma)

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patientundergo breast reconstruction can significantly decrease use of pain medications afterreconstructive surgery.

Stanford is currently accepting patients for this trial. For more information, please contact Afaaf Shakir at (650) 498-6498 .

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: TAP block
  • Other: saline infusion
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Using internal mammary system as recipient vessels.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria

   - Using recipient vessels other than internal mammary system.

   - Allergic to local anesthetics or opioids.

   - History of addiction to narcotics or other substances.

   - History of chronic pain on opioids.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant or nursing.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Now accepting new patients

Explore Related Trials

All Stanford Trials

Contact Information

Primary Contact:
Afaaf Shakir
(650) 498-6498

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305